|
01 Apr 2019 |
ADXS-PSA in Combination with KEYTRUDA® Prolonged Survival in Metastatic Castration-Resistant Prostate Cancer
|
|
30 Mar 2019 |
Preliminary Data from Phase 1 Study Evaluating ADXS-NEO Suggest Rapid Immunogenicity and Clinical Activity
|
|
27 Mar 2019 |
IAVI Announces First-in-Human Clinical Trial of Native-like HIV Envelope Vaccine Candidate
|
|
25 Mar 2019 |
European Phase 3 Trial of Aimmune Therapeutics’ AR101 Meets Primary Endpoint
|
|
22 Mar 2019 |
Gritstone Oncology Announces First Patient Dosed in a Clinical Study Evaluating its Personalized Immunotherapy, GRANITE-001
|
|
20 Mar 2019 |
Vaxart Announces Initiation of Bivalent Norovirus Vaccine Phase 1b Clinical Trial
|
|
20 Mar 2019 |
PDC*line Pharma enters into a licensing agreement with leading Korean pharmaceutical company LG Chem to develop PDC*lung cancer vaccine in Asia
|
|
20 Mar 2019 |
SOTIO’s DCVAC/OvCa Significantly Improves Survival in Patients with Recurrent Ovarian Cancer
|
|
20 Mar 2019 |
Emergent BioSolutions Initiates Phase 3 Clinical Study to Evaluate AV7909 for Post-Exposure Prophylaxis of Anthrax
|
|
19 Mar 2019 |
Allergy Therapeutics announces top-line Phase III results from its B301 clinical trial
|
|
19 Mar 2019 |
Amphera Recruits First Patients to Pivotal Phase II/III study of MesoPher to Treat Pleural Mesothelioma
|
|
19 Mar 2019 |
IMV and Centre de Recherche du CHU de Québec-Université Laval Collaboration Awarded a CQDM Grant to Develop First-in-Class Dual Target T Cell Therapy in Bladder Cancer Based on IMV’s DPX Technology
|
|
19 Mar 2019 |
China National Biotec Group (CNBG) and ImmunoBiology Ltd Enter Licensing Agreement to Co-Develop Next Generation Vaccine against Pneumococcal Disease in Greater China
|
|
19 Mar 2019 |
U.S. FDA Accepts BLA Filing of Aimmune Therapeutics’ AR101 for Peanut Allergy
|
|
06 Mar 2019 |
Transgene to start clinical development of lead myvacTM individualized immunotherapy, TG4050, in 2019, under its partnership with NEC
|
|
04 Mar 2019 |
Inovio Initiates REVEAL 2 Global Phase 3 Clinical Study For the Treatment of HPV-Related Cervical Pre-cancer
|
|
02 Mar 2019 |
Pfizer Announces Serotypes Included in 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older
|
|
02 Mar 2019 |
Heat Biologics Presents Interim Phase 2 Lung Cancer Data on HS-110 + Nivolumab at ASCO-SITC Clinical Immuno-Oncology Symposium
|
|
28 Feb 2019 |
Novavax Announces Topline Results from Phase 3 PrepareTM Trial of ResVax™ for Prevention of RSV Disease in Infants via Maternal Immunization
|
|
15 Feb 2019 |
New Clinical Data Analysis Shows Survival Benefit Three Years after Treatment with Sipuleucel-T
|
|
14 Feb 2019 |
Advaxis Announces Enrollment of the First Patient in its Phase 1/2 Trial for ADXS-HOT in the Treatment of Non-Small Cell Lung Cancer
|
|
13 Feb 2019 |
Moderna Announces Positive Interim Phase 1 Data for First Combination Vaccine Against the Respiratory Viruses hMPV and PIV3
|
|
13 Feb 2019 |
Affinivax, Inc. Announces Initiation of Phase 1/2 Clinical Study of ASP3772, Its Novel Pneumococcal MAPS Vaccine, in Collaboration with Astellas
|
|
12 Feb 2019 |
FluGen’s M2SR Influenza Vaccine Succeeds in Phase 2 Human Challenge Trial Against a Highly Mismatched Virus
|
|
04 Feb 2019 |
VLP Therapeutics to Initiate First Clinical Trial of VLPM01 Malaria Vaccine
|
